Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, Antonia Le Gruyer, François Habersetzer: A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. In: New England Journal of Medicine. 6. Juni 2018, doi:10.1056/NEJMoa1714519.
nih.gov
ncbi.nlm.nih.gov
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. PMID 10880410
